Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Beavis

Showing results (31-40 of 92) with videos related to

Pageof 10
Sort By:
Cancer Research|March 8, 2012
CD73-deficient mice are resistant to carcinogenesisJohn Stagg, Paul A Beavis, Upulie Divisekera, et al.
The Journal of Allergy and Clinical Immunology|October 24, 1997
The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-gamma production by cultured primary CD4+ T cellsS P Umland, D K Nahrebne, S Razac, et al.
Cancer Cell|July 14, 2021
The role of exhaustion in CAR T cell therapyGreg M Delgoffe, Chenqi Xu, Crystal L Mackall, et al.
Mucosal Immunology|February 4, 2016
Host innate inflammatory factors and staphylococcal protein A influence the duration of human Staphylococcus aureus nasal carriageA L Cole, G Muthukrishnan, C Chong, et al.
Oncoimmunology|October 10, 2015
CD73: A potential biomarker for anti-PD-1 therapyPaul A Beavis, Clare Y Slaney, Nicole Milenkovski, et al.
Drug and Alcohol Dependence|April 19, 2021
Randomized controlled trial of group motivational interviewing for veterans with substance use disordersElizabeth J Santa Ana, Steven D LaRowe, Mulugeta Gebregziabher, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2011
Resistance to regulatory T cell-mediated suppression in rheumatoid arthritis can be bypassed by ectopic foxp3 expression in pathogenic synovial T cellsPaul A Beavis, Bernard Gregory, Patricia Green, et al.
Oncoimmunology|July 4, 2015
Cross-talk between tumors can affect responses to therapyChristel Devaud, Liza B John, Jennifer A Westwood, et al.
Cancer Immunology Research|February 13, 2015
Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell ResponsesPaul A Beavis, Nicole Milenkovski, Melissa A Henderson, et al.
Nature Reviews. Clinical Oncology|March 1, 2020
Tissue-resident memory T cells in breast cancer control and immunotherapy responsesAnn Byrne, Peter Savas, Sneha Sant, et al.
Pageof 10

Showing results (31-40 of 92) with videos related to

Sort By:
Pageof 10
Cancer Research|March 8, 2012
CD73-deficient mice are resistant to carcinogenesisJohn Stagg, Paul A Beavis, Upulie Divisekera, et al.
The Journal of Allergy and Clinical Immunology|October 24, 1997
The inhibitory effects of topically active glucocorticoids on IL-4, IL-5, and interferon-gamma production by cultured primary CD4+ T cellsS P Umland, D K Nahrebne, S Razac, et al.
Cancer Cell|July 14, 2021
The role of exhaustion in CAR T cell therapyGreg M Delgoffe, Chenqi Xu, Crystal L Mackall, et al.
Mucosal Immunology|February 4, 2016
Host innate inflammatory factors and staphylococcal protein A influence the duration of human Staphylococcus aureus nasal carriageA L Cole, G Muthukrishnan, C Chong, et al.
Oncoimmunology|October 10, 2015
CD73: A potential biomarker for anti-PD-1 therapyPaul A Beavis, Clare Y Slaney, Nicole Milenkovski, et al.
Drug and Alcohol Dependence|April 19, 2021
Randomized controlled trial of group motivational interviewing for veterans with substance use disordersElizabeth J Santa Ana, Steven D LaRowe, Mulugeta Gebregziabher, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 20, 2011
Resistance to regulatory T cell-mediated suppression in rheumatoid arthritis can be bypassed by ectopic foxp3 expression in pathogenic synovial T cellsPaul A Beavis, Bernard Gregory, Patricia Green, et al.
Oncoimmunology|July 4, 2015
Cross-talk between tumors can affect responses to therapyChristel Devaud, Liza B John, Jennifer A Westwood, et al.
Cancer Immunology Research|February 13, 2015
Adenosine Receptor 2A Blockade Increases the Efficacy of Anti-PD-1 through Enhanced Antitumor T-cell ResponsesPaul A Beavis, Nicole Milenkovski, Melissa A Henderson, et al.
Nature Reviews. Clinical Oncology|March 1, 2020
Tissue-resident memory T cells in breast cancer control and immunotherapy responsesAnn Byrne, Peter Savas, Sneha Sant, et al.
Pageof 10